ArticleFibrosis (Hong Kong, China)2023

Translational Studies Reveal the Divergent Effects of Simtuzumab Targeting LOXL2 in Idiopathic Pulmonary Fibrosis.

Milena S Espindola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.